( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author Wikidata ID:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):

Yajun Guo

Wikidata Item | Scholia Profile [curation] | Reasonator | SQID

Listed Publications

60 publications found

TitleAuthors (identified)Published InIdentifier(s)TopicPublished Date
Enantiomeric separation of vilanterol trifenatate by chiral liquid chromatography[1]Yajun Guo, [2]Yulei Yang, [3]Jiajuan Peng, [4]Xueyan Zhu, [5]Zongde Ji [Full author list]Chirality [curation]DOI: 10.1002/CHIR.23105
PubMed: 31392772
chirality [curation]; enantiomer [curation]2019-08-08
Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system[1]Qing An, [2]Yingxin Zheng, [3]Yirong Zhao, [4]Tao Liu, [5]Huaizu Guo, [6]Dapeng Zhang, [7]Weizhu Qian, [8]Hao Wang, [9]Yajun Guo, [10]Sheng Hou, [11]Jing Li [Full author list]Drug Design, Development and Therapy [curation]DOI: 10.2147/DDDT.S170913
PubMed: 30880912
infliximab [curation]; biosimilar [curation]; drug discovery [curation]; pharmaceutical science [curation]2019-01-01
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer[1]Xi Chen, [2]Jin Xu, [3]Qingcheng Guo, [4]Lingfei Wang, [5]Yun Yang, [6]Huaizu Guo, [7]Nana Gu, [8]Dapeng Zhang, [9]Weizhu Qian, [10]Sheng Hou, [11]Jing Li, [12]Jianxin Dai, [13]Yajun Guo, [14]Hao Wang [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2016.10.011
PubMed: 27720718
colorectal cancer [curation]2016-10-05
In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.[1]Boning Liu, [2]Huaizu Guo, [3]Junjie Zhang, [4]Jingya Xue, [5]Yun Yang, [6]Ting Qin, [7]Jin Xu, [8]Qingcheng Guo, [9]Dapeng Zhang, [10]Weizhu Qian, [11]Bohua Li, [12]Sheng Hou, [13]Jianxin Dai, [14]Yajun Guo, [15]Hao Wang [Full author list]Molecular Pharmaceutics [curation]DOI: 10.1021/ACS.MOLPHARMACEUT.6B00280
PubMed: 27377124
2016-07-05
Acid-induced aggregation propensity of nivolumab is dependent on the Fc.[1]Boning Liu, [2]Huaizu Guo, [3]Jin Xu, [4]Ting Qin, [5]Lu Xu, [6]Junjie Zhang, [7]Qingcheng Guo, [8]Dapeng Zhang, [9]Weizhu Qian, [10]Bohua Li, [11]Jianxin Dai, [12]Sheng Hou, [13]Yajun Guo, [14]Hao Wang [Full author list]Monoclonal Antibodies [curation]DOI: 10.1080/19420862.2016.1197443
PubMed: 27310175
2016-06-16
Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells[1]Yantao Li, [2]Tuo Fu, [3]Tao Liu, [4]Huaizu Guo, [5]Qingcheng Guo, [6]Jin Xu, [7]Dapeng Zhang, [8]Weizhu Qian, [9]Jianxin Dai, [10]Bohua Li, [11]Yajun Guo, [12]Sheng Hou, [13]Hao Wang [Full author list]Monoclonal Antibodies [curation]DOI: 10.1080/19420862.2016.1172150
PubMed: 27050807
L-Alanine [curation]2016-04-06
Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy[1]Yun Yang, [2]Qingcheng Guo, [3]Xi Chen, [4]Junjie Zhang, [5]Huaizu Guo, [6]Weizhu Qian, [7]Sheng Hou, [8]Jianxin Dai, [9]Bohua Li, [10]Yajun Guo, [11]Hao Wang [Full author list]Monoclonal Antibodies [curation]DOI: 10.1080/19420862.2015.1127491
PubMed: 26760045
overexpression [curation]2016-01-13
Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency[1]Yun Yang, [2]Qingcheng Guo, [3]Mao Xia, [4]Yantao Li, [5]Xiaoyun Peng, [6]Tao Liu, [7]Xin Tong, [8]Jin Xu, [9]Huaizu Guo, [10]Weizhu Qian, [11]Sheng Hou, [12]Jianxin Dai, [13]Hao Wang, [14]Rong Liu, [15]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.1080/19420862.2015.1008352
PubMed: 25679409
2015-01-01
Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression[1]Guangchao Li, [2]Likun Zhao, [3]Wei Li, [4]Kexing Fan, [5]Weizhu Qian, [6]Sheng Hou, [7]Hao Wang, [8]Jianxin Dai, [9]Huafeng Wei, [10]Yajun Guo [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.2135
PubMed: 25327561
trastuzumab [curation]2014-09-01
Comparison of the inhibition mechanisms of Adalimumab and Infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.[1]Shi Hu, [2]Shuaiyi Liang, [3]Huaizu Guo, [4]Dapeng Zhang, [5]Hui Li, [6]Xiaoze Wang, [7]Weili Yang, [8]Weizhu Qian, [9]Sheng Hou, [10]Hao Wang, [11]Yajun Guo, [12]Zhiyong Lou [Full author list]Journal of Biological Chemistry [curation]DOI: 10.1074/JBC.A113.491530
adalimumab [curation]2014-08-01
Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMab[1]Lei Zhao, [2]Feiyue Xie, [3]Xin Tong, [4]Huafei Li, [5]Yaling Chen, [6]Weizhu Qian, [7]Shuyan Duan, [8]Juan Zheng, [9]Ziye Zhao, [10]Bohua Li, [11]Dapeng Zhang, [12]Jian Zhao, [13]Jianxin Dai, [14]Hao Wang, [15]Sheng Hou, [16]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.4161/MABS.28613
PubMed: 24670986
non-Hodgkin lymphoma [curation]2014-03-26
Antibody-targeted immunoliposomes for cancer treatment[1]Jie Gao, [2]Huaiwen Chen, [3]Hao Song, [4]Xiao Su, [5]Fangfang Niu, [6]Wei Li, [7]Bohua Li, [8]Jianxin Dai, [9]Hao Wang, [10]Yajun Guo [Full author list]Mini-Reviews in Medicinal Chemistry [curation]DOI: 10.2174/1389557513666131119202717
PubMed: 24251805
2013-12-01
Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFP.[1]Lei Zhao, [2]Qin Tong, [3]Weizhu Qian, [4]Bohua Li, [5]Dapeng Zhang, [6]Tuo Fu, [7]Shuyan Duan, [8]Xueguang Zhang, [9]Jian Zhao, [10]Jianxin Dai, [11]Hao Wang, [12]Sheng Hou, [13]Yajun Guo [Full author list]Blood [curation]DOI: 10.1182/BLOOD-2013-04-496554
PubMed: 24178967
non-Hodgkin lymphoma [curation]2013-10-31
Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View[1]Shi Hu, [2]Shuaiyi Liang, [3]Huaizu Guo, [4]Dapeng Zhang, [5]Hui Li, [6]Xiaoze Wang, [7]Weili Yang, [8]Weizhu Qian, [9]Sheng Hou, [10]Hao Wang, [11]Yajun Guo, [12]Zhiyong Lou [Full author list]Journal of Biological Chemistry [curation]DOI: 10.1074/JBC.M113.491530
PubMed: 23943614
cell biology [curation]; adalimumab [curation]2013-09-20
Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.[1]Jie Gao, [2]Huaiwen Chen, [3]Yongsheng Yu, [4]Jinjing Song, [5]Hao Song, [6]Xiao Su, [7]Wei Li, [8]Xin Tong, [9]Weizhu Qian, [10]Hao Wang, [11]Jianxin Dai, [12]Yajun Guo [Full author list]Biomaterials [curation]DOI: 10.1016/J.BIOMATERIALS.2013.08.088
PubMed: 24060417
doxorubicin [curation]; hepatocellular carcinoma [curation]2013-09-20
Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma[1]Jie Gao, [2]Yu Xia, [3]Huaiwen Chen, [4]Yongsheng Yu, [5]Jinjing Song, [6]Wei Li, [7]Weizhu Qian, [8]Hao Wang, [9]Jianxin Dai, [10]Yajun Guo [Full author list]Nanomedicine [curation]DOI: 10.2217/NNM.13.20
PubMed: 23721168
nanoparticle [curation]; antibody [curation]; drug delivery [curation]2013-05-31
The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy[1]Wei Li, [2]Li Zhang, [3]Ge Zhang, [4]Huafeng Wei, [5]Mengxin Zhao, [6]Huafei Li, [7]Shangjing Guo, [8]Jie Gao, [9]Geng Kou, [10]Bohua Li, [11]Jianxin Dai, [12]Hao Wang, [13]Yajun Guo [Full author list]Mini-Reviews in Medicinal Chemistry [curation]DOI: 10.2174/1389557511313050003
PubMed: 23469780
immunotherapy [curation]; cancer immunotherapy [curation]; nanocarrier [curation]2013-04-01
Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles[1]Wei Li, [2]He Zhao, [3]Weizhu Qian, [4]Huafei Li, [5]Li Zhang, [6]Zengwei Ye, [7]Ge Zhang, [8]Mao Xia, [9]Jinfeng Li, [10]Jie Gao, [11]Bohua Li, [12]Geng Kou, [13]Jianxin Dai, [14]Hao Wang, [15]Yajun Guo [Full author list]Biomaterials [curation]DOI: 10.1016/J.BIOMATERIALS.2012.04.016
PubMed: 22542611
chemotherapy [curation]2012-04-28
Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release[1]Wei Li, [2]Qingchenig Guo, [3]He Zhao, [4]Li Zhang, [5]Jinfeng Li, [6]Jie Gao, [7]Weizhu Qian, [8]Bohua Li, [9]Huaiwen Chen, [10]Hao Wang, [11]Jianxin Dai, [12]Yajun Guo [Full author list]Nanomedicine [curation]DOI: 10.2217/NNM.11.100
PubMed: 22385198
2012-03-01
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjects[1]Bo Zhou, [2]Birong Lin, [3]Jing Li, [4]Weizhu Qian, [5]Sheng Hou, [6]Dapeng Zhang, [7]Geng Kou, [8]Bohua Li, [9]Hao Wang, [10]Yongchuan Chen, [11]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.4161/MABS.4.1.18349
PubMed: 22327434
pharmacokinetics [curation]; pharmacodynamics [curation]2012-01-01
The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes[1]Jie Gao, [2]Wei Liu, [3]Yu Xia, [4]Wei Li, [5]Jing Sun, [6]Huaiwen Chen, [7]Bohua Li, [8]Dapeng Zhang, [9]Weizhu Qian, [10]Yanchun Meng, [11]Li Deng, [12]Hao Wang, [13]Jianming Chen, [14]Yajun Guo [Full author list]Biomaterials [curation]DOI: 10.1016/J.BIOMATERIALS.2011.01.034
PubMed: 21296406
antibody [curation]; overexpression [curation]2011-05-01
The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors[1]Wei Li, [2]Jinfeng Li, [3]Jie Gao, [4]Bohua Li, [5]Yu Xia, [6]Yanchun Meng, [7]Yongsheng Yu, [8]Huaiwen Chen, [9]Jianxin Dai, [10]Hao Wang, [11]Yajun Guo [Full author list]Biomaterials [curation]DOI: 10.1016/J.BIOMATERIALS.2011.01.075
PubMed: 21377724
micelles [curation]2011-03-05
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice[1]Kexing Fan, [2]Bo Zhang, [3]Haiou Yang, [4]Huajing Wang, [5]Min Tan, [6]Sheng Hou, [7]Weizhu Qian, [8]Bohua Li, [9]Hao Wang, [10]Jianxin Dai, [11]Yajun Guo [Full author list]European Journal of Pharmacology [curation]DOI: 10.1016/J.EJPHAR.2011.01.041
PubMed: 21300057
2011-02-25
Identification of a novel functional domain of ricin responsible for its potent toxicity[1]Jianxing Dai, [2]Lei Zhao, [3]Haiou Yang, [4]Huaizu Guo, [5]Kexing Fan, [6]Huaqing Wang, [7]Weizhu Qian, [8]Dapeng Zhang, [9]Bohua Li, [10]Hao Wang, [11]Yajun Guo [Full author list]Journal of Biological Chemistry [curation]DOI: 10.1074/JBC.M110.196584
PubMed: 21303906
2011-02-08
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors[1]Chong Wang, [2]Xiaohui He, [3]Bo Zhou, [4]Jing Li, [5]Bohua Li, [6]Weizhu Qian, [7]Sheng Hou, [8]Hao Wang, [9]Yuankai Shi, [10]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.4161/MABS.3.1.14021
PubMed: 21051930
antibody [curation]; monoclonal antibody [curation]2011-01-01
Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma[1]Bohua Li, [2]Xunming Zhang, [3]Shu Shi, [4]Lei Zhao, [5]Dapeng Zhang, [6]Weizhu Qian, [7]Lei Zheng, [8]Jie Gao, [9]Hao Wang, [10]Yajun Guo [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-10-0009
PubMed: 20631068
2010-07-14
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts[1]Jing Li, [2]Bo Zhou, [3]Jianzhong Shentu, [4]Li Du, [5]Min Tan, [6]Sheng Hou, [7]Weizhu Qian, [8]Bohua Li, [9]Dapeng Zhang, [10]Jianxin Dai, [11]Hao Wang, [12]Xu Zhang, [13]Jianghua Chen, [14]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.4161/MABS.12305
PubMed: 20519962
phase I clinical trial [curation]2010-07-01
Development and characterization of a novel anti-IgE monoclonal antibody[1]Weizhu Qian, [2]Xunmin Zhang, [3]Bohua Li, [4]Dapeng Zhang, [5]Qing Tong, [6]Lin Chen, [7]Lei Zheng, [8]Geng Kou, [9]Hao Wang, [10]Sheng Hou, [11]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2010.04.063
PubMed: 20394728
2010-04-13
Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein[1]Dapeng Zhang, [2]Bohua Li, [3]Jingping Shi, [4]Lei Zhao, [5]Xunming Zhang, [6]Chong Wang, [7]Sheng Hou, [8]Weizhu Qian, [9]Geng Kou, [10]Hao Wang, [11]Yajun Guo [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-09-3488
PubMed: 20197464
endothelium [curation]2010-03-02
Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma[1]Lan Wu, [2]Chong Wang, [3]Dapeng Zhang, [4]Xunming Zhang, [5]Weizhu Qian, [6]Lei Zhao, [7]Hao Wang, [8]Bohua Li, [9]Yajun Guo [Full author list]Cancer Letters [curation]DOI: 10.1016/J.CANLET.2009.12.004
PubMed: 20056316
2010-01-06
Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing[1]Jie Gao, [2]Jing Sun, [3]Huimei Li, [4]Wei Liu, [5]Yang Zhang, [6]Bohua Li, [7]Weizhu Qian, [8]Hao Wang, [9]Jianming Chen, [10]Yajun Guo [Full author list]Biomaterials [curation]DOI: 10.1016/J.BIOMATERIALS.2009.11.112
PubMed: 20035999
gene silencing [curation]2009-12-24
The protein-protein interface evolution acts in a similar way to antibody affinity maturation[1]Bohua Li, [2]Lei Zhao, [3]Chong Wang, [4]Huaizu Guo, [5]Lan Wu, [6]Xunming Zhang, [7]Weizhu Qian, [8]Hao Wang, [9]Yajun Guo [Full author list]Journal of Biological Chemistry [curation]DOI: 10.1074/JBC.M109.076547
PubMed: 20007707
protein evolution [curation]2009-12-10
Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma[1]Bohua Li, [2]Lei Zhao, [3]Huaizu Guo, [4]Chong Wang, [5]Xunming Zhang, [6]Lan Wu, [7]Lin Chen, [8]Qing Tong, [9]Weizhu Qian, [10]Hao Wang, [11]Yajun Guo [Full author list]Blood [curation]DOI: 10.1182/BLOOD-2009-06-225474
PubMed: 19828699
rituximab [curation]2009-10-14
Development and characterization of a fully functional small anti-HER2 antibody[1]Jie Gao, [2]Bohua Li, [3]Huimei Li, [4]Xunmin Zhang, [5]Dapeng Zhang, [6]Lei Zhao, [7]Chong Wang, [8]Chen Fang, [9]Weizhu Qian, [10]Sheng Hou, [11]Geng Kou, [12]Huafeng Wei, [13]Shu Shi, [14]Hao Wang, [15]Yajun Guo [Full author list]BMB Reports [curation]DOI: 10.5483/BMBREP.2009.42.10.636
PubMed: 19874707
2009-10-01
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo[1]Jianxin Dai, [2]Bohua Li, [3]Jinping Shi, [4]Ling Peng, [5]Dapeng Zhang, [6]Weizhu Qian, [7]Sheng Hou, [8]Lei Zhao, [9]Jie Gao, [10]Zhiguo Cao, [11]Jian Zhao, [12]Hao Wang, [13]Yajun Guo [Full author list]Cancer Immunology, Immunotherapy [curation]DOI: 10.1007/S00262-009-0754-Z
PubMed: 19690854
antibody [curation]2009-08-19
Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice[1]Huafeng Wei, [2]Suhui Wang, [3]Dapeng Zhang, [4]Sheng Hou, [5]Weizhu Qian, [6]Bohua Li, [7]Huaizu Guo, [8]Geng Kou, [9]Jinqiu He, [10]Hao Wang, [11]Yajun Guo [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-08-3321
PubMed: 19584156
dendritic cell [curation]2009-07-07
Genetically targeted T cells eradicate established breast cancer in syngeneic mice[1]Hao Wang, [2]Huafeng Wei, [3]Ruiping Zhang, [4]Sheng Hou, [5]Bohua Li, [6]Weizhu Qian, [7]Dapeng Zhang, [8]Gen Kou, [9]Jianxin Dai, [10]Yajun Guo [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-08-2381
PubMed: 19188165
2009-02-01
A functional motif QLYxxYP is essential for osteopontin induced T lymphocyte activation and migration.[1]Jianxin Dai, [2]Zhiguo Cao, [3]Yanshen Kang, [4]Kexing Fan, [5]Guanghui Ji, [6]Haiou Yang, [7]Huajing Wang, [8]Jie Gao, [9]Hao Wang, [10]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2009.01.157
PubMed: 19285028
2009-01-29
Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study[1]Jing Li, [2]Xinyan Li, [3]Min Tan, [4]Birong Lin, [5]Sheng Hou, [6]Weizhu Qian, [7]Bohua Li, [8]Dapeng Zhang, [9]Bo Zhou, [10]Hao Wang, [11]Tongyu Zhu, [12]Yajun Guo [Full author list]Monoclonal Antibodies [curation]DOI: 10.4161/MABS.1.1.7399
PubMed: 20046574
2009-01-01
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab') fragments[1]Jie Gao, [2]Geng Kou, [3]Huaiwen Chen, [4]Hao Wang, [5]Bohua Li, [6]Ying Lu, [7]Dapeng Zhang, [8]Shuhui Wang, [9]Sheng Hou, [10]Weizhu Qian, [11]Jianxin Dai, [12]Jian Zhao, [13]Yanqiang Zhong, [14]Yajun Guo [Full author list]Molecular Cancer Therapeutics [curation]DOI: 10.1158/1535-7163.MCT-08-0514
PubMed: 18852143
nanoparticle [curation]; hepatocellular carcinoma [curation]2008-10-01
Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab[1]Lei Zheng, [2]Bohua Li, [3]Weizhu Qian, [4]Lei Zhao, [5]Zhiguo Cao, [6]Shu Shi, [7]Jie Gao, [8]Dapeng Zhang, [9]Sheng Hou, [10]Jianxin Dai, [11]Hao Wang, [12]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2008.08.055
PubMed: 18725193
antibody [curation]; monoclonal antibody [curation]2008-08-24
A novel functional motif of osteopontin for human lymphocyte migration and survival[1]Zhiguo Cao, [2]Jianxin Dai, [3]Kexin Fan, [4]Huajing Wang, [5]Guanghui Ji, [6]Bohua Li, [7]Dapeng Zhang, [8]Sheng Hou, [9]Weizhu Qian, [10]Jian Zhao, [11]Hao Wang, [12]Yajun Guo [Full author list]Molecular Immunology [curation]DOI: 10.1016/J.MOLIMM.2008.06.008
PubMed: 18632157
2008-07-15
Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection[1]Geng Kou, [2]Shuhui Wang, [3]Changming Cheng, [4]Jie Gao, [5]Bohua Li, [6]Hao Wang, [7]Weizhu Qian, [8]Sheng Hou, [9]Dapeng Zhang, [10]Jianxin Dai, [11]Hongchen Gu, [12]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2008.06.126
PubMed: 18621023
nanoparticle [curation]; hepatocellular carcinoma [curation]2008-07-11
Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling[1]Sheng Hou, [2]Bohua Li, [3]Ling Wang, [4]Weizhu Qian, [5]Dapeng Zhang, [6]Xueyu Hong, [7]Hao Wang, [8]Yajun Guo [Full author list]Journal of Biochemistry [curation]DOI: 10.1093/JB/MVN052
PubMed: 18424812
antibody [curation]; monoclonal antibody [curation]2008-07-01
Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells[1]Kexing Fan, [2]Jianxin Dai, [3]Hao Wang, [4]Huafeng Wei, [5]Zhiguo Cao, [6]Sheng Hou, [7]Weizhu Qian, [8]Huaqing Wang, [9]Bohua Li, [10]Jian Zhao, [11]Huji Xu, [12]Chengde Yang, [13]Yajun Guo [Full author list]Arthritis & Rheumatology [curation]DOI: 10.1002/ART.23490
PubMed: 18576331
antibody [curation]; monoclonal antibody [curation]2008-07-01
PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity[1]Jie Gao, [2]Geng Kou, [3]Hao Wang, [4]Huaiwen Chen, [5]Bohua Li, [6]Ying Lu, [7]Dapeng Zhang, [8]Shuhui Wang, [9]Sheng Hou, [10]Weizhu Qian, [11]Jianxin Dai, [12]Jian Zhao, [13]Yanqiang Zhong, [14]Yajun Guo [Full author list]Breast Cancer Research and Treatment [curation]DOI: 10.1007/S10549-008-0043-0
PubMed: 18481173
nanoparticle [curation]; tumor progression [curation]; breast neoplasm [curation]2008-05-15
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells[1]Huafeng Wei, [2]Hao Wang, [3]Bing Lu, [4]Bohua Li, [5]Sheng Hou, [6]Weizhu Qian, [7]Kexing Fan, [8]Jianxin Dai, [9]Jian Zhao, [10]Yajun Guo [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-07-6051
PubMed: 18483270
dendritic cell [curation]; immunotherapy [curation]2008-05-01
Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity[1]Bohua Li, [2]Shu Shi, [3]Weizhu Qian, [4]Lei Zhao, [5]Dapeng Zhang, [6]Sheng Hou, [7]Lei Zheng, [8]Jianxin Dai, [9]Jian Zhao, [10]Hao Wang, [11]Yajun Guo [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-07-6663
PubMed: 18381448
antibody [curation]2008-04-01
Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity.[1]Weizhu Qian, [2]Ling Wang, [3]Bohua Li, [4]Hao Wang, [5]Sheng Hou, [6]Xueyu Hong, [7]Dapeng Zhang, [8]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2007.12.184
PubMed: 18190781
2008-01-09
A chimeric SM5-1 antibody inhibits hepatocellular carcinoma cell growth and induces caspase-dependent apoptosis[1]Jianxin Dai, [2]Jun Jin, [3]Bohua Li, [4]Hao Wang, [5]Sheng Hou, [6]Weizhu Qian, [7]Geng Kou, [8]Dapeng Zhang, [9]Jing Li, [10]Min Tan, [11]Jing Ma, [12]Yajun Guo [Full author list]Cancer Letters [curation]DOI: 10.1016/J.CANLET.2007.09.002
PubMed: 17959303
cell growth [curation]2007-10-23
Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance[1]Kexing Fan, [2]Hao Wang, [3]Huafeng Wei, [4]Qian Zhou, [5]Geng Kou, [6]Sheng Hou, [7]Weizhu Qian, [8]Jianxin Dai, [9]Bohua Li, [10]Yanyun Zhang, [11]Tongyu Zhu, [12]Yajun Guo [Full author list]Transplantation [curation]DOI: 10.1097/01.TP.0000280545.14489.DF
PubMed: 17893608
2007-09-27
Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.[1]Huajing Wang, [2]Jianxin Dai, [3]Bohua Li, [4]Kexing Fan, [5]Lin Peng, [6]Dapeng Zhang, [7]Zhiguo Cao, [8]Weizhu Qian, [9]Hao Wang, [10]Jian Zhao, [11]Yajun Guo [Full author list]Protein Expression and Purification [curation]DOI: 10.1016/J.PEP.2007.09.009
PubMed: 17950620
2007-09-19
Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody[1]Geng Kou, [2]Jie Gao, [3]Hao Wang, [4]Huaiwen Chen, [5]Bohua Li, [6]Dapeng Zhang, [7]Shuhui Wang, [8]Sheng Hou, [9]Weizhu Qian, [10]Jianxin Dai, [11]Yanqiang Zhong, [12]Yajun Guo [Full author list]BMB Reports [curation]DOI: 10.5483/BMBREP.2007.40.5.731
PubMed: 17927907
nanoparticle [curation]; antibody [curation]2007-09-01
Functional and stable expression of recombinant human FOXP3 in bacterial cells and development of antigen-specific monoclonal antibodies[1]Shuiqing Hu, [2]Jianxin Dai, [3]Huafeng Wei, [4]Kexing Fan, [5]Huajing Wang, [6]Dapeng Zhang, [7]Weizhu Qian, [8]Bohua Li, [9]Hao Wang, [10]Tongyu Zhu, [11]Yanyun Zhang, [12]Yajun Guo [Full author list]Journal of Biochemistry [curation]DOI: 10.1093/JB/MVM160
PubMed: 17761693
2007-08-30
Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody[1]Bohua Li, [2]Hao Wang, [3]Dapeng Zhang, [4]Weizhu Qian, [5]Sheng Hou, [6]Shu Shi, [7]Lei Zhao, [8]Geng Kou, [9]Zhiguo Cao, [10]Jianxin Dai, [11]Yajun Guo [Full author list]Biochemical and Biophysical Research Communications [curation]DOI: 10.1016/J.BBRC.2007.04.039
PubMed: 17451647
2007-04-17
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome.[1]Hao Wang, [2]Shuichuan Song, [3]Geng Kou, [4]Bohua Li, [5]Dapeng Zhang, [6]Sheng Hou, [7]Weizhu Qian, [8]Jianxin Dai, [9]Liang Tian, [10]Jian Zhao, [11]Yajun Guo [Full author list]Cancer Immunology, Immunotherapy [curation]DOI: 10.1007/S00262-007-0321-4
PubMed: 17431617
xenograft [curation]2007-04-13
Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.[1]Sheng Hou, [2]Geng Kou, [3]Xiaoqiang Fan, [4]Hao Wang, [5]Weizhu Qian, [6]Dapeng Zhang, [7]Bohua Li, [8]Jianxin Dai, [9]Jian Zhao, [10]Jing Ma, [11]Jing Li, [12]Birong Lin, [13]Mengchao Wu, [14]Yajun Guo [Full author list]Cancer Immunology, Immunotherapy [curation]DOI: 10.1007/S00262-007-0306-3
PubMed: 17361437
gene therapy [curation]; hepatocellular carcinoma [curation]; colon cancer [curation]2007-03-15
Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli[1]Geng Kou, [2]Shu Shi, [3]Hao Wang, [4]Min Tan, [5]Jingya Xue, [6]Dapeng Zhang, [7]Sheng Hou, [8]Weizhu Qian, [9]Shuhui Wang, [10]Jianxin Dai, [11]Bohua Li, [12]Yajun Guo [Full author list]Protein Expression and Purification [curation]DOI: 10.1016/J.PEP.2006.08.007
PubMed: 17027283
Escherichia coli [curation]2006-08-23
Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions[1]Bohua Li, [2]Hao Wang, [3]Jianxin Dai, [4]Junjie Ji, [5]Weizhu Qian, [6]Dapeng Zhang, [7]Sheng Hou, [8]Yajun Guo [Full author list]Immunology [curation]DOI: 10.1111/J.1365-2567.2005.02247.X
PubMed: 16313362
2005-12-01
Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy[1]Hao Wang, [2]Jianxin Dai, [3]Sheng Hou, [4]Weizhu Qian, [5]Bohua Li, [6]Jing Ma, [7]Xiaoqiang Fan, [8]Jian Zhao, [9]Shilin Yang, [10]Hongxun Sang, [11]Qing Yang, [12]Rongfu Wang, [13]Yajun Guo [Full author list]Cancer Gene Therapy [curation]DOI: 10.1038/SJ.CGT.7700843
PubMed: 15877081
Adenoviridae [curation]; gene therapy [curation]2005-09-01
Correct Q number of author item for selected works.
NO replacement author: revert to author name strings

Common author items in these papers

Common names in these papers


Feedback
Source and documentation (at github)
Wikidata page